News About: Pharm. Industry
4 innovative pharmaceutical firms to receive award from government
The Ministry of Health and Welfare has recently unveiled its plan to offer an award to four innovative pharmaceutical firms that are widely recognized to stimulate the country’s research and development (R&D) for new ...
Sluggish sales hit drugmakers
Korean drug firms have seen lackluster sales amid the prolonged economic slump. The firms are struggling to deplete increasing volumes of stocked drug products, fallout from a prolonged downturn in the local industry....
Dong-A cerebrates Bacchus on 50-year birthday
Dong-A pharmaceutical on Aug. 8 said it held a ceremony celebrating the golden anniversary of Korea’s noncarbonated Bacchus at its headquarters in Yongsan-dong, central Seoul, attended by Kang Shin-ho, chairman of Don...
Korean drugmakers at a crossroads
Many experts say that the country's medicine business is standing at a crossroads. Is it going take a leap with new, innovative drugs or continue chasing global leaders with generic products?
The Korea Pharmaceutic...
Dongwha apologizes for trouble over anti-diarrheal medicine Lacteol
Donwha Pharm issued a public apology Thursday for causing an inconvenience over the wrong active ingredient used in anti-diarrheal medicine Lacteol (tyndalized lactobacillus acidophilus) and its generic versions,
T...
Tax exemptions set for facility spending
Tax breaks will be differently given for the corporate investment in upgrading the quality control of drugmakers’ production facility.
According to the revised tax code released by the Ministry of Strategy and Fina...
MSD Korea names new director for Diversified Business UnitMSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., announced today that Lim Kwang-heok was appointed director of its Diversified Business Unit as of Aug. 5, ...
|
Korea's improved version of Nexium obtains final approval from US FDA
An incrementally modified (IMD) drug developed by a Korean drug company that treats gastro-esophageal reflex disease has received a final approval from the U.S. Food and Drug Administration (FDA) for the first time.
...
Celltrion to conduct clinical trials for Remsima in the U.S.
Celltrion said Monday it has filed an application of its antibody drug Remsima for the U.S. Food and Drug Administration in a bid to carry out its clinical tests there.
It will take about six months to receive the ...
Korea wins U.S. patent for recombinant anthrax vaccine
The country's public health and safety agency had won an U.S. patent for the process of manufacturing a recombinant anthrax vaccine, the Korea Centers for Disease Control and Prevention (KCDC) said Tuesday.
The pat...
